|
Julia Rowland, PhD, is a psycho-oncologist by training; someone who studies cancer patient’s social, emotional, psychological and behavioral health. An experienced clinician, researcher and teacher, she is the Senior Strategic Advisor at Smith Center for Health and the Arts. Before that, she served as the National Cancer Institute’s first full-time Director of the Office of Cancer Survivorship and earlier, was founding Director of the Psycho-Oncology Program at Georgetown University and the Lombardi Cancer Center. Recently, Dr. Rowland co-chaired a panel to develop new integrative care guidelines for treating anxiety and depression in adults with cancer. In this interview, she shares information about this project, a collaboration between the American Society of Clinical Oncology (ASCO) and the Society of Integrative Oncology (SIO), and some key findings.
Could you tell me more about how the guidelines were developed?
In 2014, ASCO released its first set of recommendations for managing anxiety and depression in adults treated for cancer. The guideline was based on an adaptation of pre-existing Canadian recommendations for this care. Both guidelines, in their review of the science, focused on standard methods of treating anxiety and depression, specifically psychological, behavioral, and pharmacologic treatments, the interventions most commonly used by doctors and mental health professionals. As is their custom, ASCO sought to update their guidelines in 2023. A new panel was convened to review the literature published from 2014 to 2022 to see if any changes should be made. At the same time, the Society of Integrative Oncology (SIO) reached out to ASCO to co-develop evidence-based guidelines for use of integrative practices for managing anxiety and depression in adult cancer survivors. These latter guidelines would focus on such modalities as mind-body practices, meditation, music, yoga, etc., therapeutic techniques already available in many cancer settings. The good news is that with these two new and highly complementary publications, we now have an expanded set of interventions, both conventional and integrative, that can be used to address anxiety and depression in cancer.
When many of us think of medicine, we think of medication. Why is it important to consider other ways of treating anxiety and depression?
Anxiety and depression are increased in individuals diagnosed and treated for cancer. Left untreated, these symptoms can lead not only to poor physical health, function and quality of life, but also to increased risk of mortality. For those experiencing these conditions, intervening quickly and effectively is important. With the two new guidelines, we now have a variety of therapies that can be tailored to patients’ needs and recommended. The updated ASCO guideline does not say don't use medication. In some cases, it is needed. Further, sometimes providers may want to combine it with other interventions. Rather, the two guidelines emphasize that before turning to medications, clinicians should think first about offering non-pharmacologic options. Aside from the proven efficacy of an array of these, many cancer survivors are reluctant to take medications. Why? Drugs often have interactions with other medications being used when combined. Side effects of medications can be undesirable. In addition, a number of people prefer not to take more drugs or be labeled/seen as having a mental illness after cancer. By contrast, non-pharmacologic interventions have low risk of harm, build on healthy life-style behaviors, and especially appealing, provide cancer survivors with a way to take control of their well-being, a sense frequently lost in the wake of cancer. Most importantly, the new guidelines expand our tools for treating anxiety and depression. Is research still needed? Yes. Especially in integrative studies where we need more researchers involved.
Who are the guidelines intended for and how are they meant to be used?
The guidelines were intended primarily for use by any healthcare provider delivering care to someone with cancer or a history of cancer. However, it is also hoped that the recommendations provided within them will be shared broadly with cancer patients, survivors and their loved ones. By having clearly delineated pathways for assessing anxiety and depression, coupled with therapies to treat these conditions, we hope to reduce barriers to timely and effective care. Important to the success of this effort, is knowing which therapies are provided locally or in the community to which cancer survivors can be referred. While they may not be responsible for doing or providing treatment for anxiety and depression, healthcare professionals do act as gatekeepers. In the greater DC area, links can be made with places like the Smith Center, Hope Connections, the Life with Cancer Program, the International Arts + Mind Lab at Johns Hopkins, and the Lombardi Arts and Humanities Program.
How do you view the role of the arts as a form of care?
A key point highlighted in the SIO/ASCO integrative care guidelines is that many programs that fall under the arts umbrella, such as music, dance/movement, art therapy, can help address symptoms of anxiety and depression. Underuse of the arts in healing is the result for some of being turned off from the arts as kids; for not coloring within the lines, for a lack of imagination, being self-conscious about moving their bodies, told they have no sense of pitch or cannot play an instrument. Helping individuals rediscover these buried skills can have a powerful influence on well-being. What I find exciting is there is a growing body of science behind why these interventions are effective, a realization that we are actually wired for art!
Two companion Q & A articles for each of the 2023 guidelines, these can be found at the following links:
ASCO - https://pubmed.ncbi.nlm.nih.gov/37406256/
SIO/ASCO - https://ascopubs.org/doi/full/10.1200/OP.23.00358
|